Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 76 AL 90

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets

Zádori D, Veres G, Szalárdy L, Klivényi P, Toldi J, Vécsei L.

J Alzheimers Dis. 2014;42 Suppl 3:S177-87. doi: 10.3233/JAD-132621.

Formulations: friendly, fast, forgiving and flexible

Citrome L.

Int J Clin Pract. 2014 Apr;68(4):407. doi: 10.1111/ijcp.12420.

Treadmill training as an augmentation treatment for Alzheimer's disease: a pilot randomized controlled study

Arcoverde C, Deslandes A, Moraes H, Almeida C, Araujo NB, Vasques PE, Silveira H, Laks J.

Arq Neuropsiquiatr. 2014 Mar;72(3):190-6. doi: 10.1590/0004-282X20130231.

Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

Beauchet O, Launay CP, Allali G, Herrmann FR, Annweiler C.

Drugs Aging. 2014 May;31(5):363-72. doi: 10.1007/s40266-014-0175-3.

BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease

Ghosh AK, Osswald HL.

Chem Soc Rev. 2014 Oct 7;43(19):6765-813. doi: 10.1039/c3cs60460h.

A new regulatory road-map for Alzheimer's disease drug development

Becker RE, Greig NH.

Curr Alzheimer Res. 2014 Mar;11(3):215-20. doi: 10.2174/156720501103140329210642.

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Galasko D, Bell J, Mancuso JY, Kupiec JW, Sabbagh MN, van Dyck C, Thomas RG, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2014 Apr 29;82(17):1536-42. doi: 10.1212/WNL.0000000000000364. Epub 2014 Apr 2.

Investigational drugs in Alzheimer's disease: current progress

Berk C, Paul G, Sabbagh M.

Expert Opin Investig Drugs. 2014 Jun;23(6):837-46. doi: 10.1517/13543784.2014.905542. Epub 2014 Apr 5.

The evolution of amidine-based brain penetrant BACE1 inhibitors

Oehlrich D, Prokopcova H, Gijsen HJ.

Bioorg Med Chem Lett. 2014 May 1;24(9):2033-45. doi: 10.1016/j.bmcl.2014.03.025. Epub 2014 Mar 20.

The elusive search for solutions to Alzheimer's

Iglehart JK.

Health Aff (Millwood). 2014 Apr;33(4):526. doi: 10.1377/hlthaff.2014.0253.

Optimizing person-centered transitions in the dementia journey: a comparison of national dementia strategies

Fortinsky RH, Downs M.

Health Aff (Millwood). 2014 Apr;33(4):566-73. doi: 10.1377/hlthaff.2013.1304.

Redesigning systems of care for older adults with Alzheimer's disease

Callahan CM, Sachs GA, Lamantia MA, Unroe KT, Arling G, Boustani MA.

Health Aff (Millwood). 2014 Apr;33(4):626-32. doi: 10.1377/hlthaff.2013.1260.

Alzheimer's disease and nursing homes

Gaugler JE, Yu F, Davila HW, Shippee T.

Health Aff (Millwood). 2014 Apr;33(4):650-7. doi: 10.1377/hlthaff.2013.1268.

Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-β aggregation inhibitors

Stoddard SV, Hamann MT, Wadkins RM.

Mar Drugs. 2014 Apr 4;12(4):2114-31. doi: 10.3390/md12042114.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias